BeStock  

Repligen RGEN

US equityMarket cap rank #1375Medical Instruments & Supplies
$163.81 −$6.48 (-3.81%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $163.81 0.00%
Open$169.61
Prev close$170.29
Day range$162.47 – $169.61
Volume697.7K
Market cap$10.47B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-799.0x
CheapRich

Near the bottom of its 5-year range · 12th percentile, 5-year average 111.3x

#2898 of 2994 stocks by PE (1 = cheapest)

Price / book5.1x
CheapRich

Above its usual level · 73rd percentile, 5-year average 4.7x

#4399 of 5331 stocks by PB (1 = cheapest)

Price / sales13.3x
CheapRich

Above its usual level · 65th percentile, 5-year average 13.1x

#4608 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-9,446x-3,058x3,330x9,718xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$171.55
Price vs. fair value-4.5%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyLow
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 5.13 – 4.69 73% (pricier than usual) #4399 of 5331 (1 = cheapest)
PE -799.00 155.00 111.31 12% (cheaper than usual) #2898 of 2994 (1 = cheapest)
PS 13.31 10.45 13.05 65% (pricier than usual) #4608 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on RGEN.

Sign in to join the discussion.

Scroll to Top